---
title: Resources
author: ZD
date: 2025-06-20
---

# Data Portals

The following data sharing resources offer access to data or analysis tools to advance cancer research. This list is based on programs available in the [Index of NCI Studies (INS)](https://studycatalog.cancer.gov) and is not exhaustive.

## INS

The **Index of NCI Studies (INS)** compiles and shares publicly available information about research outputs produced by NCI-supported programs.

[studycatalog.cancer.gov](https://studycatalog.cancer.gov)

---

## ACCSIS

**Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)** is a multi-site consortium focused on improving colorectal cancer screening rates and follow-up care through implementation science research. Studies effective strategies to increase screening uptake and reduce disparities in colorectal cancer prevention.

[ACCSIS Website](https://healthcaredelivery.cancer.gov/accsis/) | [Data Access](https://accsis.rti.org/consortium/cc/)

## All of Us

**All of Us** is a national precision medicine research program building one of the largest biomedical data resources from diverse participants across the United States. Collects health data including genomics, electronic health records, and lifestyle factors to advance cancer research and personalized cancer treatments.

[All of Us Website](https://allofus.nih.gov/) | [Data Access](https://www.researchallofus.org/)

## APOLLO

The **Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) network (APOLLO)** is a multi-institutional network that integrates proteomics and genomics data to improve cancer patient outcomes. APOLLO connects proteomic research with clinical practice to advance precision oncology and personalized treatment approaches.

[APOLLO Website](https://proteomics.cancer.gov/programs/apollo-network) | [Data Access](https://proteomics.cancer.gov/data-portal)

## ARTNet

The **Acquired Resistance to Therapy Network (ARTNet)** is a research network focused on understanding and overcoming acquired resistance to cancer therapies. Studies mechanisms of treatment resistance and develops strategies to prevent or overcome therapeutic resistance in cancer patients.

[ARTNet Website](https://www.nciartnet.org/en/) | [Data Access](https://www.nciartnet.org/en/resources/data-sharing-catalog/)

## ATOM

**Accelerating Therapeutics for Opportunities in Medicine (ATOM)** is a computational program that develops predictive models and tools to accelerate cancer drug discovery and development. ATOM integrates high-performance computing, machine learning, and experimental validation to improve therapeutic development.

[ATOM Website](https://computational.cancer.gov/about/atom) | [Data Access](https://modac.cancer.gov/)

## BETRNet

The **Barrett's Esophagus Translational Research Network (BETRNet)** is a translational research network focused on Barrett's esophagus and esophageal adenocarcinoma prevention. Studies risk factors, biomarkers, and intervention strategies to prevent progression from Barrett's esophagus to cancer.

[BETRNet Website](https://prevention.cancer.gov/major-programs/barretts-esophagus-translational-research-network-betrnet) | [Data Access](https://www.vumc.org/cqs/statistical-data-centers)

## CCBIR

**Cellular Cancer Biology Imaging Research (CCBIR)** is a research program focused on developing and applying advanced imaging technologies to study cancer biology. Supports development of imaging tools and techniques to visualize cellular processes in cancer development and treatment.

[CCBIR Website](https://www.cancer.gov/about-nci/organization/dcb/research-programs/ccbir) | [Data Access](https://www.cancercomplexity.synapse.org/)

## CCDI

The **Childhood Cancer Data Initiative (CCDI)** is a data sharing initiative focused on pediatric cancer research and data harmonization. CCDI creates a comprehensive data ecosystem to accelerate childhood cancer research and improve outcomes for pediatric cancer patients.

[CCDI Website](https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative) | [Data Access](https://ccdi.cancer.gov/home)

## CCIS

The **Consortium for Cancer Implementation Science (CCIS)** is a research consortium focused on implementation science to improve cancer prevention and control. CCIS develops and tests strategies to implement evidence-based cancer prevention and control interventions in real-world settings.

[CCIS Website](https://cancercontrol.cancer.gov/is/initiatives/ccis) | [Data Access](https://cancercontrol.cancer.gov/is/initiatives/ccis/public-goods)

## CCSS

The **Childhood Cancer Survivor Study (CCSS)** is a long-term follow-up study of childhood cancer survivors examining late effects of cancer treatment. CCSS provides data on health outcomes, quality of life, and long-term complications in childhood cancer survivors.

[CCSS Website](https://ccss.stjude.org/) | [Data Access](https://ccss.stjude.org/public-access-data.html)

## CIBMTR

The **Center for International Blood & Marrow Transplant Research (CIBMTR)** is a research collaboration that maintains a database of outcomes data on bone marrow transplants and cellular therapies used to treat blood cancers like leukemia and lymphoma. CIBMTR facilitates critical research to improve survival and quality of life for cancer patients receiving these life-saving treatments.

[CIBMTR Website](https://cibmtr.org/) | [Data Access](https://cibmtr.org/CIBMTR/Resources/Publicly-Available-Datasets#)

## CGCI

The **Cancer Genome Characterization Initiative (CGCI)** is a genomic characterization program that provides comprehensive molecular profiling of cancer samples. CGCI generates high-quality genomic data to support cancer research and therapeutic development through systematic tumor analysis.

[CGCI Website](https://www.cancer.gov/ccg/research/genome-sequencing/cgci) | [Data Access](https://portal.gdc.cancer.gov/exploration?filters=%7B%22op%22%3A%22and%22%2C%22content%22%3A%5B%7B%22op%22%3A%22in%22%2C%22content%22%3A%7B%22field%22%3A%22cases.project.program.name%22%2C%22value%22%3A%5B%22CGCI%22%5D%7D%7D%5D%7D)

## Connect

The **Connect for Cancer Prevention Study (Connect)** is a prospective cohort study using digital technologies to study cancer prevention and early detection. Connect collects health data through smartphones and wearable devices to understand cancer risk factors and prevention strategies.

[Connect Website](https://dceg.cancer.gov/research/who-we-study/cohorts/connect) | [Data Access](https://github.com/episphere/connect/wiki)

## CP-CTNet

The **Cancer Prevention Clinical Trials Network (CP-CTNet)** is a clinical trials network focused on cancer prevention and risk reduction interventions. CP-CTNet conducts multi-site clinical trials to test interventions that prevent cancer development or reduce cancer risk in high-risk populations.

[CP-CTNet Website](https://prevention.cancer.gov/major-programs/cancer-prevention-clinical-trials-network-cp-ctnet) | [Data Access](https://www.cp-ctnet-dmacc.org/public/program-resources/)

## CPTAC

The **Clinical Proteomic Tumor Analysis Consortium (CPTAC)** is a multi-institutional consortium that conducts comprehensive proteomic analysis of cancer samples from TCGA and other sources. CPTAC generates high-quality proteomic data to complement genomic information for cancer research.

[CPTAC Website](https://proteomics.cancer.gov/programs/cptac) | [Data Access](https://gdc.cancer.gov/about-gdc/contributed-genomic-data-cancer-research/clinical-proteomic-tumor-analysis-consortium-cptac)

## CSBC

The **Cancer Systems Biology Consortium (CSBC)** is a research consortium that applies systems biology approaches to understand cancer as a complex biological system. CSBC develops computational models and tools to study cancer initiation, progression, and treatment response.

[CSBC Website](https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc) | [Data Access](https://www.cancercomplexity.synapse.org/)

## CTD^2

The **Cancer Target Discovery and Development (CTD^2)** is a network that systematically identifies and validates cancer therapeutic targets through functional genomics approaches. CTD^2 develops tools and resources to accelerate translation of genomic discoveries into clinical applications.

[CTD^2 Website](https://www.cancer.gov/ccg/research/functional-genomics/ctd2) | [Data Access](https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal)

## DCEG

The **Division of Cancer Epidemiology and Genetics IRP (DCEG)** is an intramural research program conducting epidemiological studies to understand cancer causes and prevention. DCEG investigates genetic and environmental risk factors for cancer through population-based studies and provides public data resources.

[DCEG Website](https://dceg.cancer.gov/) | [Data Access](https://dceg.cancer.gov/tools/public-data)

## EDRN

The **Early Detection Research Network (EDRN)** is a research network focused on developing biomarkers and technologies for early cancer detection. EDRN conducts studies to discover, validate, and translate biomarkers for cancer screening and early detection across multiple cancer types.

[EDRN Website](https://edrn.nci.nih.gov/) | [Data Access](https://edrn.nci.nih.gov/data-and-resources/data/)

## ENICTO

**Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO)** is a research network studying exercise and nutrition interventions to help cancer patients better tolerate treatments and improve their quality of life. ENICTO conducts clinical trials testing lifestyle interventions that may reduce cancer treatment side effects and improve survival outcomes.

[ENICTO Website](https://enicto.bsc.gwu.edu/web/enicto) | [Data Access](https://enicto.bsc.gwu.edu/web/enicto/coordinating-center)

## Kids First

The **Gabriella Miller Kids First Pediatric Research Program (Kids First)** is a pediatric research program that generates and analyzes genomic data from children with cancer and structural birth defects. Kids First aims to accelerate childhood cancer research by identifying genetic causes of pediatric cancers and developing new treatments for children with cancer.

[Kids First Website](https://commonfund.nih.gov/kidsfirst) | [Data Access](https://kidsfirstdrc.org/)

## HCMI

The **Human Cancer Models Initiative (HCMI)** is an initiative developing next-generation cancer models including patient-derived organoids, cell lines, and xenografts. HCMI creates well-characterized cancer models that better represent human tumor biology for research and drug development.

[HCMI Website](https://www.cancer.gov/ccg/research/functional-genomics/hcmi) | [Data Access](https://portal.gdc.cancer.gov/projects/HCMI-CMDC)

## HTAN

The **Human Tumor Atlas Network (HTAN)** is a multi-institutional network creating comprehensive cellular maps of human cancers. HTAN uses advanced single-cell and spatial technologies to understand tumor evolution, heterogeneity, and therapeutic responses at cellular resolution.

[HTAN Website](https://humantumoratlas.org/) | [Data Access](https://humantumoratlas.org/explore)

## IDG

**Illuminating the Druggable Genome (IDG)** is a research program focused on understudied proteins that may represent novel cancer therapeutic targets. IDG systematically studies the druggable genome to identify and characterize potential drug targets for cancer treatment, particularly in understudied protein families that could lead to new cancer therapies.

[IDG Website](https://commonfund.nih.gov/idg) | [Data Access](https://druggablegenome.net/DataTools)

## IMPROVE

**Innovative Methodologies and New Data for Predictive Oncology Model Evaluation (IMPROVE)** is a computational program developing improved methods for evaluating predictive models in cancer research. IMPROVE creates standardized datasets and evaluation frameworks to assess and compare machine learning models for cancer prediction and treatment response.

[IMPROVE Website](https://computational.cancer.gov/about/improve) | [Data Access](https://computational.cancer.gov/view-dataset-finder?f%5B0%5D=dataset_project%3Aimprov)

## IOTN

The **Immuno-Oncology Translation Network (IOTN)** is a research network focused on accelerating the development and clinical translation of immunotherapy approaches for cancer. IOTN conducts studies to improve understanding of immune responses to cancer and develop more effective immunotherapies.

[IOTN Website](https://www.iotnmoonshot.org/en/) | [Data Access](https://www.iotnmoonshot.org/en/resources/data-sharing-catalog/)

## ITCR

**Advanced Development of Informatics Technologies for Cancer Research and Management (ITCR)** develops and maintains informatics technologies and computational tools to support cancer research and clinical care. The program creates software tools, databases, and algorithms to advance cancer research and management.

[ITCR Website](https://itcr.cancer.gov/about-itcr) | [Data Access](https://itcr.cancer.gov/informatics-tools)

## MCI

The **Childhood Cancer Data Initiative Molecular Characterization Initiative (MCI)** is an initiative conducting comprehensive molecular characterization of childhood cancers to improve diagnosis and treatment. This program generates genomic and other molecular data from pediatric tumor samples to advance precision medicine for childhood cancers.

[MCI Website](https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/programs/molecular-characterization) | [Data Access](https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002790.v1.p1)

## MOSSAIC

**Modeling Outcomes Using Surveillance Data and Scalable Artificial Intelligence for Cancer (MOSSAIC)** is a computational program using artificial intelligence and surveillance data to model cancer outcomes. MOSSAIC develops AI tools and models to improve cancer prevention, screening, and treatment through population-level data analysis.

[MOSSAIC Website](https://computational.cancer.gov/about/mossaic) | [Data Access](https://github.com/DOE-NCI-MOSSAIC)

## Moonshot Biobank

The **Moonshot Biobank** is a cancer-focused biobanking initiative that collects and stores high-quality tumor samples and other biospecimens from cancer patients. The biobank provides cancer researchers with access to well-characterized samples linked to clinical data to accelerate cancer research discoveries and drug development.

[Moonshot Biobank Website](https://moonshotbiobank.cancer.gov/) | [Data Access](https://moonshotbiobank.cancer.gov/)

## NCCR

The **National Childhood Cancer Registry (NCCR)** is a population-based registry collecting comprehensive data on childhood cancer cases in the United States. NCCR provides surveillance data on pediatric cancer incidence, survival, and trends to support research and public health efforts.

[NCCR Website](https://nccrexplorer.ccdi.cancer.gov/nccr.html) | [Data Access](https://nccrexplorer.ccdi.cancer.gov/data-products.html)

## NCI-MATCH

**Molecular Analysis for Therapy Choice for adults with advanced cancers (NCI-MATCH)** is a precision medicine clinical trial that matches patients with advanced cancers to targeted therapies based on tumor molecular characteristics. NCI-MATCH tests whether targeted treatment of molecular abnormalities can improve outcomes regardless of cancer type.

[NCI-MATCH Website](https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/nci-match) | [Data Access](https://ecog-acrin.org/clinical-trials/eay131-nci-match-precision-medicine/nci-match-eay131-findings/)

## NCTN

**NCI's National Clinical Trials Network (NCTN)** is a network of research organizations conducting cancer clinical trials across the United States. NCTN coordinates multi-site clinical trials to test new cancer treatments and supportive care interventions, providing access to trial data for research.

[NCTN Website](https://www.cancer.gov/research/infrastructure/clinical-trials/nctn) | [Data Access](https://nctn-data-archive.nci.nih.gov/)

## OMF

The **Oncology Models Forum (U24) (OMF)** is a research program focused on developing and characterizing cancer models including cell lines, organoids, and animal models. OMF provides resources and standards for cancer model development and validation to improve research reproducibility.

[OMF Website](https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf) | [Data Access](https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf#nci-and-omf-resources-related-to-oncology-models)

## PaCMEN

The **Pancreatic Cancer Microenvironment Network (PaCMEN)** is a research network studying the pancreatic cancer tumor microenvironment and its role in treatment resistance. PaCMEN investigates interactions between cancer cells and surrounding tissues to identify new therapeutic targets.

[PaCMEN Website](https://pacmen.org/) | [Data Access](https://pacmen.org/Dbs.html)

## PCDC

The **Pancreatic Cancer Detection Consortium (PCDC)** is a research consortium focused on early detection of pancreatic cancer through biomarker discovery and validation. PCDC develops screening tools and strategies to detect pancreatic cancer at earlier, more treatable stages.

[PCDC Website](https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc) | [Data Access](https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc/pcdc-resources-and-collaborative-opportunities)

## PDMC

**Patient-Derived Models of Cancer (PDMC)** is a research program developing patient-derived cancer models that better reflect human tumor biology. PDMC creates and characterizes models including organoids, xenografts, and cell lines from patient tumors for research and drug testing.

[PDMC Website](https://www.cancer.gov/about-nci/organization/dcb/research-programs/pdmc) | [Data Access](https://www.cancer.gov/about-nci/organization/dcb/research-programs/pdmc#nci-supported-resources-related-to-patient-derived-models)

## PDXNet

The **Patient-Derived Xenograft (PDX) Development and Trial Centers Research Network (PDXNet)** is a research network developing and utilizing patient-derived xenograft models for cancer research. PDXNet creates standardized PDX models and conducts preclinical trials to test cancer treatments and predict patient responses.

[PDXNet Website](https://www.pdxnetwork.org/) | [Data Access](https://www.pdxnetwork.org/pdccc)

## PREVENT

The **PREVENT Cancer Preclinical Drug Development Program (PREVENT)** is a preclinical research program focused on developing agents for cancer prevention and early intervention. PREVENT conducts laboratory studies to identify and test compounds that may prevent cancer development or progression.

[PREVENT Website](https://prevention.cancer.gov/major-programs/prevent-cancer-preclinical-drug-development-program-prevent) | [Data Access](https://prevention.cancer.gov/major-programs/prevent-cancer-preclinical-drug-development-program-prevent/available-resources)

## PRECINCT

The **PRE-medical Cancer Immunotherapy Network Canine Trials (PRECINCT)** is a comparative oncology network conducting immunotherapy trials in dogs with naturally occurring cancers. PRECINCT leverages canine cancer models to accelerate development of cancer immunotherapies for both dogs and humans.

[PRECINCT Website](https://www.precinctnetwork.org/) | [Data Access](https://caninecommons.cancer.gov/#/)

## PROSPR

The **Population-based Research to Optimize the Screening Process (PROSPR)** is a research consortium studying cancer screening processes and outcomes in real-world healthcare settings. PROSPR conducts population-based research to optimize screening programs for breast, cervical, and colorectal cancers.

[PROSPR Website](https://healthcaredelivery.cancer.gov/prospr/) | [Data Access](https://healthcaredelivery.cancer.gov/prospr/datashare/)

## PS-ON

The **Physical Sciences - Oncology Network (PS-ON)** is an interdisciplinary research network applying physical sciences principles to understand cancer biology. PS-ON studies cancer as a complex physical system, investigating mechanical forces, physics, and engineering approaches to cancer research.

[PS-ON Website](https://www.cancer.gov/about-nci/organization/dcb/research-programs/pson) | [Data Access](https://www.cancercomplexity.synapse.org/)

## PSRC

The **Pancreatic Adenocarcinoma Stromal Reprogramming ConSortium (PSRC/PASSCODE)** is a research consortium focused on understanding and targeting the pancreatic cancer tumor microenvironment. PSRC studies stromal reprogramming approaches to improve pancreatic cancer treatment by modifying the tumor microenvironment.

[PSRC Website](https://www.nci-psrc.org/index.html#Home) | [Data Access](https://www.nci-psrc.org/team_MDACC.html)

## SCLC

The **Small Cell Lung Cancer (SCLC) Consortium (SCLC)** is a research consortium focused on understanding and developing treatments for small cell lung cancer. SCLC Consortium conducts preclinical research to identify new therapeutic targets and treatment strategies for this aggressive cancer type.

[SCLC Website](https://prevention.cancer.gov/major-programs/small-cell-lung-cancer-sclc-consortium) | [Data Access](https://www.mskcc.org/research-programs/nci-small-cell-lung-cancer-consortium/cellminer-sclc)

## SEER

The **Surveillance, Epidemiology, and End Results (SEER)** program is a population-based cancer surveillance program that collects data on cancer incidence, survival, and prevalence in the United States. SEER provides comprehensive cancer statistics and trends to support research, public health efforts, and clinical decision-making.

[SEER Website](https://seer.cancer.gov/) | [Data Access](https://seer.cancer.gov/data-software/)

## SenNET

The **Cellular Senescence Network (SenNET)** is a research consortium studying cellular senescence and its role in cancer development and aging-related diseases. SenNet maps senescent cells across tissues and organs to understand how cellular aging contributes to cancer and identify new targets for cancer prevention and treatment.

[SenNET Website](https://sennetconsortium.org/about-2/) | [Data Access](https://data.sennetconsortium.org/search?size=n_10000_n&sort%5B0%5D%5Bfield%5D=last_modified_timestamp&sort%5B0%5D%5Bdirection%5D=desc)

## TARGET

The **Therapeutically Applicable Research to Generate Effective Treatments (TARGET)** is a genomic characterization program focused on childhood and young adult cancers. TARGET generates comprehensive molecular data from pediatric cancers to identify potential therapeutic targets and improve treatment outcomes for young cancer patients.

[TARGET Website](https://www.cancer.gov/ccg/research/genome-sequencing/target) | [Data Access](https://www.cancer.gov/ccg/)

## TCGA

**The Cancer Genome Atlas Program (TCGA)** is a landmark genomics program that molecularly characterized over 20,000 cancer samples across 33 cancer types. TCGA generated comprehensive genomic data to understand cancer biology and identify potential therapeutic targets through multi-platform molecular analysis.

[TCGA Website](https://www.cancer.gov/ccg/research/genome-sequencing/tcga) | [Data Access](https://portal.gdc.cancer.gov/)

&nbsp;  

---

**Updated:** July 8, 2025
